Search Results 571-580 of 16095 for pilule du lendemain

1. Pediatrics Clinical Trials - Medical Professionals

   To determine the effectiveness of the ARTISAN Aphakia lens in the treatment of aphakia and to precisely define the associated risks and, if possible, ...

2. Breast cancer - Doctors and departments - Mayo Clinic

   Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

3. Obstetrics and Gynecology - Clinical trials

   The postnatal diagnosis of Long QT Syndrome (LQTS) is suggested by a prolonged QT interval on 12 lead electrocardiogram (ECG),a positive family history ...

4. A Study of Oral Ixazomib Citrate (MLN9708) Maintenance Therapy in Patients with Multiple Myeloma Following Autologous Stem Cell Transplant - Mayo Clinic

   Participation eligibility · Agree to practice effective barrier contraception during the entire study treatment period and through 90 days after the last dose of ...

5. A Study to Evaluate the Safety and Immunological Effect of Pembrolizumab in Resectable or Borderline Resectable Pancreatic Cancer - Mayo Clinic

   Male subjects should agree to use an adequate method of contraception starting with the first dose of study therapy through 120 days after the last dose of ...

6. A Study to Assess the Effectiveness and Safety of Apremilast in Pediatric Patients (6 through 17 years old) with Moderate-to-Severe Plaque Psoriasis - Mayo Clinic

   ... contraception options and the correct and consistent use of effective contraceptive methods in order to successfully prevent pregnancy. Females of ...

7. Clinical trials - Oncology (Medical)

   This study aims to facilitate discovery and validation of tests for early detection in subjects at high risk for pancreatic ductal adenocarcinoma (PDAC).

8. Veliparib and Floxuridine in Treating Patients With Metastatic Epithelial Ovarian, Primary Peritoneal Cavity, or Fallopian Tube Cancer - Mayo Clinic

   Women of childbearing potential who are unwilling to employ adequate contraception (non-barrier method). Immunocompromised patients (other than that related ...

9. A Study to Evaluate Durvalumab Alone or in Combination With Novel Agents in Subjects With NSCLC - Mayo Clinic

   Females of childbearing potential and non-sterilized male subjects with female partners of childbearing potential must use effective methods of contraception ...

10. Patient Stories - Julie A. Stierwalt, Ph.D. - Mayo Clinic

    Julie A. Stierwalt, Ph.D. · Neurologic Communicative Disorder Specialist · Speech-Language Pathologist.